SANDRA NICHOLS: Open Payments
NPI 1770749202 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 34 payments from 12 companies in 2025. Trend: 2023 $1,628 · 2024 $883 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $317 |
| Otsuka America Pharmaceutical, Inc. | 7 | $157 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| UROGEN PHARMA, INC. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: VRAYLAR, REXULTI, AUSTEDO XR, CAPLYTA, ABILIFY MAINTENA, INGREZZA, SPRAVATO, Jornay PM.
Industry payments across VA — which companies pay providers there.
